✦ LIBER ✦

Scopolamine prevents the development of sensitization to methamphetamine

✍ Scribed by T. Ohmori; T. Abekawa; T. Koyama

Book ID: 118347290
Publisher: Elsevier Science
Year: 1995
Tongue: English
Weight: 573 KB
Volume: 56
Category: Article
ISSN: 0024-3205
DOI: 10.1016/0024-3205(95)00062-b

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clonazepam Prevents the Development of S

Clonazepam Prevents the Development of Sensitization to Methamphetamine

✍ K Ito; T Ohmori; T Abekawa; T Koyama 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 105 KB

Scopolamine prevents augmentation of ste

Scopolamine prevents augmentation of stereotypy induced by chronic methamphetamine treatment

✍ T. Ohmori; T. Abekawa; T. Koyama 📂 Article 📅 1995 🏛 Springer 🌐 English ⚖ 760 KB

Effects of repeated treatment with metha

Effects of repeated treatment with methamphetamine plus scopolamine and methamphetamine on behavioral sensitization and conditioning

✍ Kunio Yui; Takao Miura; Kimihito Sugiyama; Mamoru Ono; Moriharu Nagase 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 675 KB

Does Scopolamine Block the Development o

Does Scopolamine Block the Development of Ethanol-Induced Behavioral Sensitization?

✍ Shirley Takahashi; Raquel Vechio Fornari; Isabel Marian Hartmann Quadros; Maria 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 643 KB

Importance of Initial Environments in th

Importance of Initial Environments in the Development of Ambulatory Sensitization to Methamphetamine and Cocaine in Mice

✍ Hisashi Kuribara 📂 Article 📅 1998 🏛 Pharmaceutical Press 🌐 English ⚖ 673 KB

Behavioral sensitization to methamphetam

Behavioral sensitization to methamphetamine in the rat: an ontogenic study

✍ Y. Fujiwara; Y. Kazahaya; M. Nakashima; M. Sato; S. Otsuki 📂 Article 📅 1987 🏛 Springer 🌐 English ⚖ 333 KB

The behavioral effect of repeated methamphetamine (MAP) treatment was observed in young rat to establish the ontogenetic period crucial to methamphetamine sensitization. Animals were treated with MAP (2 mg/kg, SC) once daily for 5 days (Group 1: postnatal days 2-6, G-2: 7-11, G-3: 12-16, G-4: 17-21,